Effectiveness of anti-psychotic in GPs setting - Serenity
Study identifier:SRP-NB-SER-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
SERENITY: Evaluating the effectiveness of atypical antipsychotics in the community - a prospective, multicentre, observational study to evaluate the impact on Quality of Life of GP-bases management of antipsychotic treatment in Belgium.
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
250
Study type
Observational
Age
18 Years - 65 Years
Date
Study Start Date: 01 Jan 2007
Primary Completion Date: -
Study Completion Date: 01 Jun 2008
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Pitchot W Pr
ULg
